RespInnovation SAS

RESPIN WRAP & RESPIN PAD

RespIn Wrap

The Wrap is easy to put on, with elasticated side and shoulder section to ensure a snug homogeneous fit around the entire thorax. The Velcro attachments make the 3 different sized WRAPs adjustable to cover all sizes from Child's size up to XXL. There are 2 pressure piston lines on the front of the Wrap and 3 on the rear of the WRAP where our lungs are longer. The pressure piston lines action sequentially from bottom to top to not only mobilize the secretions but also to help in their transport from the smaller bronchi to the larger central bronchi for expectoration.

It is ideal for a variety of respiratory illnesses with chronic obstruction, COPDs, Neuromuscular diseases, the elderly and even Post Op due to ability to turn the front section of the WRAP off and only treat the rear where there are no sensors or other interferences in Post Op Acute Care areas.

The easy to clean Wrap can be machine washed or wiped down with anti-bacterial spray or wipes.

RespIn Pad

The newest advancement in Bronchial Clearance therapy – the RespIn Pad.

Unique and exceptionally easy to use, the RespIn Pad delivers 'focused pulsations' to the patient in super comfortable and highly effective manner – literally pick your programme, lean back against the Pad in a high backed chair or in an inclined bed or wheelchair, press the ON button and your patients can get the benefits of its our patented 'focused pulse' technology to mobilize excess secretions.

Patients can use this while watching TV, reading or working on your tablet or computer – choose from pre-installed Programmes as well as the capacity to set up and memorize your own personalized Custom programme and with our touchscreen technology you have simple easy to use 15 – 30 minute programmes ideally suited to you or your patient and their personal needs.

Ideal for Post Op to help clear airways to speedier release from ICU with no more worrying about interfering with ECG leads, ports, or other medical monitoring attached to the patient’s thorax – just lie patient back against the Pad, select therapy, press ON and the therapy is automatically carried out for the selected time and programme.

The patient groups who will more easily benefit from the ease of use and delivery of the 'focused pulse' bronchial clearance therapy are:

• Patients with limited mobility, including wheel chair bound neuromuscular patients.
• Long term bed ridden who are at high risk of secretions pooling, thickening and becoming infected leading to pneumonia or other serious and potentially life threatening pulmonary diseases.
• Post – Op patients in ICU to ensure their airways are clear for an earlier release into standard hospital care or home care.
• Preventative care for the elderly and other at-risk patient groups to keep secretions mobile to reduce incidences of chest infections in home setting, retirement or assisted living centres thereby increasing their quality of life and reducing risk of life threatening chest infections.

FEATURES

'focused pulse'

Delivers therapeutic 'focused pulse' therapy direct to selected parts of the patient thorax creating a more profound and efficient resonance in the bronchial airways which is delivered in a comfortable "massage like" therapy.

Flexible

Flexibility of RespIn 11 'focused pulse' technology also gives treating clinicians greatly increased control and flexibility of therapy to best meet the needs of each individual patient and clinical condition.

Customize

Customized clinical therapy - 'focused pulse' therapy to selected parts of patient thorax, thus giving increased control, flexibility and choice of therapy to the treating clinician. Including up to 3 stored programmable custom therapies for individual needs.

Time

Reduce time taken on trips to Physio for CPT therapy or on family members themselves taking the role of CPT giver for 45 minutes on average 1 or 2 times per day.

Comfort

Very low background pressure - The RespIn 11 patented system of focused pulsations operates at a very low background pressure which is very beneficial to patients on both a comfort level during treatment and also therapeutic level with greatly increased efficiency in dislodging mucus and assisting its movement for expectoration.

Efficacy

No negative physiological side effects - as a beneficial side effect of its low operating pressure of RespIn 11's 'focused pulse' technology, it has no negative side effects to the patient’s physiological parameters, e.g. blood pressure and heart rate, and the RespIn 11 can therefore be safely used with a much wider range of patients and clinical conditions than existing Chest Compression devices.

Tolerance

This means not only a wider range of potential patients in clinical situations, but also a much higher regular usage rate for Home Care patients because of its pleasant massage effect leading to better long term results with accompanying improvements in quality of life and decreased frequency of acute exacerbations requiring hospital treatment.

Virtuous Circle

All of these features help to create our "virtuous circle". Easier to Tolerate - More Frequent Use - Better Long Term Results - Less Acute Exacerbations - Better Quality of Life - Breathe Easier, Live Better.

'FOCUSED PULSE'

Up until 30 years ago, traditional CPT with postural drainage was the only method available to treat Chronic Obstructions of Bronchial Airways caused by diseases such as Cystic Fibrosis (CF), chronic bronchitis and asthma, emphysema, bronchiectasis, and many others (now classed together as Chronic Obstructive Pulmonary Disorders (COPD). Without this treatment the bronchial obstructions would become infected, pass to pneumonia and left untreated can cause eventual loss of Pulmonary Vital Capacity – which translates into the body’s ability to transfer oxygen taken into the lungs into the blood to supply the brain and the body.

30 years ago, High Frequency Chest Compression devices were developed and usually have treatment sessions which last 30 minutes 2 or 3 times per day. This is a very physically demanding form of therapy for the patients as it transfers a great deal of energy to the patient’s entire thorax using a high content background pressure then repeatedly squeezing the thorax up to 20 times per second to create the air movement in the airways to dislodge secretions. It can be effective, but it has a limited range of patients who are capable of tolerating the high level of energy transfer which therefore limits the number and type of clinical applications. In effect, weak or fragile patients cannot tolerate this type of therapy and must rely on CPT or drug therapy.

Our ‘focused pulsation’ therapy is completely different, it starts from the premise of treating specific zones of the thorax by transferring a focused pulsation of energy to the ribcage which then propagates this energy in a wave evenly through the lungs and bronchial tree soliciting vibrations in the bronchial tree breaking up and dislodging mucus from the bronchiole walls and helping to transport this to the larger airways for expectoration. 'focused pulse' transfers only 10% of the energy to the patient that High Frequency Chest Compression devices or HFCWO therapy devices do. This means for the patient that they only need to be able to tolerate 1/10th of the energy that existing devices on the market today deliver. This alone makes for a much more comfortable therapy for the patients very much like a gentle massage.

In addition, our clinical and scientific studies have shown that 'focused pulse' technology in the RespIn 11 creates amplitudes of reaction movement 4 – 6 times greater in the most important area of the lungs (from the 5th to 15th generation of the bronchial tree) where most mucus accumulates, therefore more effectively dislodging secretions and soliciting coughing.

CLINICAL USE

Improve safety and wider range of clinical use - RespIn 11 does not cause important negative changes to various patient physiological parameters, ie making BP, HR rise as do existing HFCWO/Chest Compression devices. In fact, Pre-Clinical Trial Safety Study data shows both those figures gradually reducing during therapy sessions of 15 or 20 minutes.

Safety and test subject feedback has been unanimous in indicating their preference for the RespIn 11 'focus pulse' system. The RespIn 11 has a very low level of clinically measurable impact on the physiological state of the patient during therapy sessions with no negative measured effects on heart rate, blood pressure, ECG, etc. - unlike the existing HFCWO/Chest Compression devices which cause patients significant physiological changes and distress. This means not only a wider range of potential patients in clinical situations, but also a much higher regular usage rate for Home Care patients because of its pleasant massage effect leading to better long term results with accompanying improvements in quality of life and decreased frequency of acute acerbations requiring hospital treatment.

Clinical Areas and applications where RespInnovation’s 'focused pulse' technology could be used more effectively than existing Chest Compression devices:

Neuro-muscular disease patients, MS, ALS, etc. / The long term bed care patient. / The elderly, both as a preventative therapy to prevent lung infections and also a secretion clearance system once they have an infection. / Intensive care and post-operative patients.

Download Clinical Trial White Paper...

Download

CONDITIONS & DISEASES

In cystic fibrosis, primary ciliary dyskinesia, or bronchiectasis, secretion clearance therapy is an established standard of care. However, in conditions other than primary disorders of the mucociliary system, Airway Clearance Therapy is generally prescribed when an individual patient's pulmonary health is compromised by adverse events arising from one or more risk factors. Others include:

Cystic Fibrosis (CF)	Muscular dystrophy (MD)
Asthma	Amyotrophic Lateral Sclerosis (ALS)
Bronchiectasis	Spinal Muscular Atrophy (SMA)
Chronic Obstructive Pulmonary Disease (COPD)	Primary Ciliary Dyskinesia (PCD)
Cerebral Palsy (CP)	Spinal Cord Injury

HFCWO has been studied extensively. Safety and efficacy are established by more than 80 clinical trials conducted at over 60 research institutions. Peer-reviewed studies demonstrate that HFCWO clears mucus and helps improve or maintain pulmonary functions more effectively than conventional chest physiotherapy (CPT).